News & events Upcoming events Mar 17, 2026 - Mar 21, 2026 AD/PD™ 2026 - Alzheimer's & Parkinson's Diseases Conference Copenhagen, Denmark More info and meet us there Mar 18, 2026 - Mar 21, 2026 EUROGIN 2026 – International Multidisciplinary HPV Congress Vienna, Austria More info and meet us there Mar 25, 2026 - Mar 26, 2026 SIBIOC conferenza strategica Milano, Italy More info and meet us there See all upcoming events Latest news May 12, 2020 iAMP COVID-19 Detection kit, a molecular SARS-CoV-2 detection assay distributed by Fujirebio Europe, is now CE marked Fujirebio Europe today announced that the molecular IVD assay iAMP COVID-19 Detection Kit from its partner Atila Biosystems, Inc. has been CE marked. Read more Apr 24, 2020 Fujirebio Europe launches the automated Lumipulse® G SCC assay for the quantitative measurement of squamous cell carcinoma antigen Fujirebio Europe announces the release of the Lumipulse G SCC assay for the automated quantitative measurement of squamous cell carcinoma (SCC) antigen in human serum or plasma. Read more Apr 14, 2020 Statement on the impact of coronavirus disease COVID-19 on our operations The novel coronavirus disease Covid-19 first reported in Wuhan, China in late 2019 has spread far beyond China, and now affects approximately 200 countries. Read more Apr 8, 2020 Fujirebio Europe launches iAMP COVID-19, a new molecular detection assay that eliminates the need for RNA extraction Fujirebio Europe N.V. today announced the commercial launch of the iAMP COVID-19 molecular assay from its partner Atila Biosystems, Inc., hereby complementing Fujirebio's existing product portfolio. Read more Mar 30, 2020 Statement on the impact of coronavirus disease COVID-19 on our operations The novel coronavirus disease Covid-19 first reported in Wuhan, China in late 2019 has spread far beyond China, and now affects approximately 200 countries. Read more Mar 16, 2020 Statement on the impact of coronavirus disease COVID-19 on our operations The novel coronavirus disease Covid-19 first reported in Wuhan, China in late 2019 has spread beyond China. While the majority of cases are in China, as of this date there are confirmed infections in over 60 countries, on all continents. Read more Load More
Mar 17, 2026 - Mar 21, 2026 AD/PD™ 2026 - Alzheimer's & Parkinson's Diseases Conference Copenhagen, Denmark More info and meet us there
Mar 18, 2026 - Mar 21, 2026 EUROGIN 2026 – International Multidisciplinary HPV Congress Vienna, Austria More info and meet us there
May 12, 2020 iAMP COVID-19 Detection kit, a molecular SARS-CoV-2 detection assay distributed by Fujirebio Europe, is now CE marked Fujirebio Europe today announced that the molecular IVD assay iAMP COVID-19 Detection Kit from its partner Atila Biosystems, Inc. has been CE marked. Read more
Apr 24, 2020 Fujirebio Europe launches the automated Lumipulse® G SCC assay for the quantitative measurement of squamous cell carcinoma antigen Fujirebio Europe announces the release of the Lumipulse G SCC assay for the automated quantitative measurement of squamous cell carcinoma (SCC) antigen in human serum or plasma. Read more
Apr 14, 2020 Statement on the impact of coronavirus disease COVID-19 on our operations The novel coronavirus disease Covid-19 first reported in Wuhan, China in late 2019 has spread far beyond China, and now affects approximately 200 countries. Read more
Apr 8, 2020 Fujirebio Europe launches iAMP COVID-19, a new molecular detection assay that eliminates the need for RNA extraction Fujirebio Europe N.V. today announced the commercial launch of the iAMP COVID-19 molecular assay from its partner Atila Biosystems, Inc., hereby complementing Fujirebio's existing product portfolio. Read more
Mar 30, 2020 Statement on the impact of coronavirus disease COVID-19 on our operations The novel coronavirus disease Covid-19 first reported in Wuhan, China in late 2019 has spread far beyond China, and now affects approximately 200 countries. Read more
Mar 16, 2020 Statement on the impact of coronavirus disease COVID-19 on our operations The novel coronavirus disease Covid-19 first reported in Wuhan, China in late 2019 has spread beyond China. While the majority of cases are in China, as of this date there are confirmed infections in over 60 countries, on all continents. Read more
